AzTrials
AzTrials

SleepI-SLEPTNCT07317336

I-SLEPT: Integrated Sleep and Life Engagement Program for Transitions

A study testing I-SLEPT in people with Sleep and Participation, run by VA Office of Research and Development at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Sleep is essential to functional recovery in inpatient medical settings; however, sleep is likely to be disrupted during rehabilitation and hospital admissions. Adverse effects of these disruptions do not subside after discharge, leading to additional consequences such as poor physical function. Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Sleep, Participation
What is being tested?
I-SLEPT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
22 Jun 2026to 31 Mar 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Admitted to and discharged from VA Boston acute care units OR Community Living Center subacute rehabilitation unit
  • English-speaking
  • Discharged to a home setting
  • Has capacity and does not have severe cognitive impairment
  • Obtains a score >= 8 on the Brief Interview for Mental Status (BIMS)
  • Endorses at least 2 items as "Rarely/Never" or "Sometimes" on the RuSATED measure AND/OR endorses they are achieving their goals at a "much worse" or "a little worse" level on the What Matters Most Tool

Who cannot join

  • Discharged from Long-Term Care, Hospice and Palliative Care, or Spinal Cord Injury bed specialty
  • Discharged from intensive care units
  • Moderate to severe dementia diagnosis, delirium, or active psychosis
  • Healthcare proxy is activated in electronic health record
  • A diagnosis of a disorder of hypersomnolence, non-REM parasomnia, or Nightmare Disorder as indicated in electronic health record
  • High acute risk for suicide

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Julia T Boyle, PsyD contact

(617) 963-6391

julia.boyle@va.gov

Jennifer A Moye, PhD contact

(774) 826-3721

Jennifer.Moye@va.gov

United States1 site, 1 recruiting
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

    Boston, Massachusetts, 02130-4817

    Julia T Boyle, PsyD, (617) 963-6391, julia.boyle@va.gov

    Jennifer A Moye, PhD, (774) 826-3721, Jennifer.Moye@va.gov

    Recruiting

Other trials in United States

About this study

Sleep is essential to functional recovery in inpatient medical settings; however, sleep is likely to be disrupted during rehabilitation and hospital admissions. Adverse effects of these disruptions do not subside after discharge, leading to additional consequences such as poor physical function. Veterans are particularly impacted by poor sleep and medical complexities that can lead to injuries requiring rehabilitative care to support their recovery. This may be more apparent in older Veteran populations. After discharge, Veterans must re-acclimate to their home environment while facing potential changes in their sleep, life engagement (e.g., pleasant activities, physical function), and health. This study will create the I-SLEPT (Integrated Sleep and Life Engagement Program for Transitions) intervention, which will support Veterans by stabilizing their sleep and by maximizing participation in meaningful activities during a critical and vulnerable period of recovery.

Read the detailed description

This project will create I-SLEPT (Integrated Sleep and Life Engagement Program for Transitions), a novel intervention to enhance sleep health and life engagement during the transition period following discharge from VA acute hospitalization and/or subacute rehabilitation. The development of I-SLEPT will be informed by both Veterans and experts. Including the Veteran perspective is essential to reflect Veterans' choice, ensure access to timely care, and prioritize effective care solutions to improve Veterans' health and well-being. Veterans are more likely to report poor sleep and medical complexities than non-Veterans which may further complicate their readjustment to their home environment after discharge. The proposed study is a single arm clinical trial. Veterans aged 50+ discharged home from VA Boston's acute care hospital units or subacute rehabilitation units at VA Boston's Community Living Center will be recruited to complete surveys and interviews informing I-SLEPT creation (Aim 1; N=20), complete a preliminary trial (Aim 2; N=5) or complete a single-arm Proof-of-Concept trial (Aim 3; N=40). Veterans participating in Aims 2 or 3 will complete assessments of sleep health and life engagement, as well as acceptability measures. Results may also inform future work adapting this intervention to other transitional phases (e.g., discharge from acute hospitalization), support Veterans across the lifespan, and support intervention implementation by staff from multiple disciplines and specialties, including nursing, social work, physical therapy, occupational therapy, and Veteran peer specialists.

Conditions
Sleep, Participation
Being tested
I-SLEPT
Keywords
sleep, participation, rehabilitation, transitions of care, physical function, hospitalization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • I-SLEPTBehavioural

    Veterans in Aim 3 will complete I-SLEPT, a 4-week telehealth intervention, delivered by a licensed clinical psychologist. Sessions will take place once a week for 60 minutes primarily using VA Video Connect. Sessions will include components focused on 1) promoting sleep health through education and habits and 2) increase engagement in meaningful activities.

Study groups in NCT07317336
Study groupRoleWhat they receive
I-SLEPTExperimentalVeterans in Aim 3 will complete I-SLEPT, a 4-week telehealth intervention, delivered by a licensed clinical psychologist. Sessions will take place once a week for 60 minutes primarily using VA Video Connect. Sessions will include components focused on 1) promoting sleep health through education and habits and 2) increase engagement in meaningful activities.
Receives: Behavioral: I-SLEPT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. RuSATED

    A brief 6-item measure encompassing the dimensions of sleep health: Regularity, Satisfaction, Alertness, Timing, Efficiency, and Duration. Scores range from 0 to 12 with higher total scores suggesting better sleep health. Items are rated on a 3-point scale from 0 to 2 (with 0 = Rarely/Never; 1 = Sometimes; and 2 = Usually/Always).

    Measured: Baseline, Endpoint (30 day), 3 Month

  2. What Matters Most (WMM) Tool

    A one-page brief tool presenting 3 domains (Staying Independent, Enjoying Life, and Connecting), each containing a list of 9 items with the option of adding a 10th item of their own. Veterans will be asked to identify up to 3 items within each domain that matters most to them. After up to 9 items total have been identified, Veterans will be asked to "pick the most important thing" and describe what this would look like for them "day to day or week to week." Veterans will be encouraged to pick up to 3 things that matter most above all. Finally, Veterans are asked to rate how well they are achieving their life engagement goals and what matters most to them, employing a 5-point Likert-style goal attainment scale (+2 = much better than expected; +1 = a little better than expected; 0 = as expected; -1 = a little worse than expected; -2 = much worse than expected). A score of 0-2 indicate satisfactory goal attainment in the area of life engagement.

    Measured: Baseline, Endpoint (30 day), 3 Month

  3. Acceptability of Intervention Measure (AIM)

    A 4-item measure that assess acceptability, defined here as the perception that I-SLEPT is acceptable, palatable, or satisfactory. Items are scored as follows: 1 - completely disagree; 2 - disagree; 3 - neither agree nor disagree; 4 - agree; 5 - completely agree. Total scores are from 4 to 20 with higher scores indicating better acceptability of the intervention.

    Measured: Endpoint (30 day)

  4. Feasibility of Intervention Measure (FIM)

    A 4-item measure that assesses feasibility defined here as the extent to which the session material can be successfully used - defined as from the Veteran's perspective of applying what is learned after the session. Items are scored as follows: 1 - completely disagree; 2 - disagree; 3 - neither agree nor disagree; 4 - agree; 5 - completely agree. Total scores are from 4 to 20 with higher scores indicating better feasibility of the intervention.

    Measured: Endpoint (30 day)

Secondary outcomes (1)
  1. Intervention Appropriateness Measure (IAM)

    A 4-item measure that assesses appropriateness, defined here as the Veteran's perspective on the perceived fit, relevance, or compatibility of session material to the Veteran's sleep health and life engagement concerns. Items are scored as follows: 1 - completely disagree; 2 - disagree; 3 - neither agree nor disagree; 4 - agree; 5 - completely agree. Total scores are from 4 to 20 with higher scores indicating better appropriateness of the intervention.

    Measured: Endpoint (30 day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2026
  2. Study start22 Jun 2026
  3. Primary completion31 Mar 2031 (estimated)
  4. Study completion31 Mar 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Assess for feasibility and clinically significant results of I-SLEPT in a proof-of-concept, single-arm trail in Veterans (Enrollment Target; N = 60) age 50 years and older who were recently discharged from VA Boston Subacute Rehabilitation to home. Targeting 40 completers.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07317336
Sponsor's protocol ID
RRD9-010-25M
Other IDs
1IK2RD000347-01A1
Acronym
I-SLEPT
Status last verified
Oct 2026
First submitted
19 Dec 2025
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing I-SLEPT in people with Sleep and Participation, run by VA Office of Research and Development at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Julia T Boyle, PsyD ((617) 963-6391, julia.boyle@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

RuSATED (time frame: Baseline, Endpoint (30 day), 3 Month). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in